Found: 213
Select item for more details and to access through your institution.
Gastrointestinal Follicular Lymphoma of the Cecum Treated via Endoscopic Full-Thickness Resection.
- Published in:
- ACG Case Reports Journal, 2024, v. 11, n. 8, p. 1, doi. 10.14309/crj.0000000000001466
- By:
- Publication type:
- Article
Analysis of aqueous 2,4,6-trinitrotoluene (TNT) using a fluorescent displacement immunoassay.
- Published in:
- Analytical & Bioanalytical Chemistry, 2003, v. 375, n. 4, p. 471, doi. 10.1007/s00216-002-1713-0
- By:
- Publication type:
- Article
Tyrosine phosphatases as regulators of skeletal development and metabolism.
- Published in:
- Journal of Cellular Biochemistry, 2005, v. 96, n. 2, p. 262, doi. 10.1002/jcb.20515
- By:
- Publication type:
- Article
The tyrosine phosphatase, OST-PTP, is expressed in mesenchymal progenitor cells early during skeletogenesis in the mousePart of this work was presented as an Abstract at the 2002 American Society for Bone and Mineral Research meeting, San Antonio, TX [Yunker et al., 2002].
- Published in:
- Journal of Cellular Biochemistry, 2004, v. 93, n. 4, p. 761, doi. 10.1002/jcb.20183
- By:
- Publication type:
- Article
BCR::ABL1 digital PCR for treatment‐free remission prediction in chronic myeloid leukemia patients: An individual participant data meta‐analysis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1632, doi. 10.1002/ajh.27359
- By:
- Publication type:
- Article
Multicenter evaluation of efficacy and toxicity of venetoclax‐based combinations in patients with accelerated and blast phase myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. E7, doi. 10.1002/ajh.26381
- By:
- Publication type:
- Article
Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 46, doi. 10.1002/ajh.25306
- By:
- Publication type:
- Article
First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1214, doi. 10.1002/ajh.24887
- By:
- Publication type:
- Article
Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 606, doi. 10.1002/ajh.24360
- By:
- Publication type:
- Article
Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 11, p. 1060, doi. 10.1002/ajh.24174
- By:
- Publication type:
- Article
On-Chip Optical Interconnects.
- Published in:
- Intel Technology Journal, 2004, v. 8, n. 2, p. 129
- By:
- Publication type:
- Article
GIANNI VATTIMO, CHARLES TAYLOR Y LOS COROLARIOS POLÍTICOS DE LA HERMENÉUTICA.
- Published in:
- Revista de Estudios Políticos, 2021, n. 194, p. 43, doi. 10.18042/cepc/rep.194.02
- By:
- Publication type:
- Article
Single-Cell Transcriptomics Links Loss of Human Pancreatic β-Cell Identity to ER Stress.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 12, p. 3585, doi. 10.3390/cells10123585
- By:
- Publication type:
- Article
The panbiogeograpy of hagfishes: a reply to Briggs’s anachronistic criticism.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Track analysis of the marine palaeofauna from the Turonian (Late Cretaceous).
- Published in:
- Journal of Biogeography, 2007, v. 34, n. 7, p. 1167, doi. 10.1111/j.1365-2699.2006.01681.x
- By:
- Publication type:
- Article
Phage-displayed peptides as biosensor reagents.
- Published in:
- Journal of Molecular Recognition, 2000, v. 13, n. 6, p. 382, doi. 10.1002/1099-1352(200011/12)13:6<382::AID-JMR511>3.0.CO;2-W
- By:
- Publication type:
- Article
The mouse DXZ4 homolog retains Ctcf binding and proximity to Pls3 despite substantial organizational differences compared to the primate macrosatellite.
- Published in:
- Genome Biology, 2012, v. 13, n. 8, p. 1, doi. 10.1186/gb-2012-13-8-r70
- By:
- Publication type:
- Article
Quasi-Steady Analysis of a Small Wind Rotor with Swept Blades.
- Published in:
- Sustainability (2071-1050), 2023, v. 15, n. 13, p. 10211, doi. 10.3390/su151310211
- By:
- Publication type:
- Article
Long‐term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome–positive leukemia resistant or intolerant to prior therapy.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 6, p. 808, doi. 10.1111/ejh.13608
- By:
- Publication type:
- Article
Back to the future: Treatment‐free remission and pregnancy in chronic myeloid leukemia.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 2, p. 197, doi. 10.1111/ejh.13192
- By:
- Publication type:
- Article
REPAIRABILITY OF AGED RESIN COMPOSITES MEDIATED BY DIFFERENT RESTORATIVE SYSTEMS.
- Published in:
- Acta Odontologica Latinoamericana: AOL, 2016, v. 29, n. 2, p. 7
- By:
- Publication type:
- Article
REPAIRABILITY OF AGED RESIN COMPOSITES MEDIATED BY DIFFERENT RESTORATIVE SYSTEMS.
- Published in:
- Acta Odontologica Latinoamericana: AOL, 2016, v. 29, n. 1, p. 7
- By:
- Publication type:
- Article
Response Dynamics in Chronic-Phase Chronic Myeloid Leukemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 3, p. 217, doi. 10.3816/CLM.2009.n.043
- By:
- Publication type:
- Article
Regulators of Telomerase Activity.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2002, v. 26, n. 5, p. 521, doi. 10.1165/ajrcmb.26.5.f238
- By:
- Publication type:
- Article
Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid Leukemia.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 12, p. e2347950, doi. 10.1001/jamanetworkopen.2023.47950
- By:
- Publication type:
- Article
Combined quantification of intracellular (phospho-)proteins and transcriptomics from fixed single cells.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37977-7
- By:
- Publication type:
- Article
Slow westward movement of salinity anomalies across the tropical South Indian Ocean.
- Published in:
- Journal of Geophysical Research. Oceans, 2015, v. 120, n. 8, p. 5436, doi. 10.1002/2015JC010933
- By:
- Publication type:
- Article
Evaluating SODA for Indo- Pacific Ocean decadal climate variability studies.
- Published in:
- Journal of Geophysical Research. Oceans, 2014, v. 119, n. 11, p. 7854, doi. 10.1002/2014JC010175
- By:
- Publication type:
- Article
Tracheostomy Decannulation and Disorders of Consciousness Evolution.
- Published in:
- Respiratory Care, 2022, v. 67, n. 2, p. 209, doi. 10.4187/respcare.08301
- By:
- Publication type:
- Article
Farmer Knowledge and Risk Analysis: Postrelease Evaluation of Herbicide-Tolerant Canola in Western Canada.
- Published in:
- Risk Analysis: An International Journal, 2008, v. 28, n. 2, p. 463, doi. 10.1111/j.1539-6924.2008.01027.x
- By:
- Publication type:
- Article
PURAS MENTIRAS. COMUNICACIONES EN CRISIS.
- Published in:
- Perspectivas de la Comunicación, 2023, v. 16, n. 2, p. 1, doi. 10.56754/0718-4867.2023.3494
- By:
- Publication type:
- Article
Fatal Human Case of Zika and Chikungunya Virus Co-Infection with Prolonged Viremia and Viruria.
- Published in:
- Diseases, 2018, v. 6, n. 3, p. 53, doi. 10.3390/diseases6030053
- By:
- Publication type:
- Article
Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research.
- Published in:
- Genetics, 2020, v. 216, n. 4, p. 905, doi. 10.1534/genetics.120.303596
- By:
- Publication type:
- Article
Multimodal Long Noncoding RNA Interaction Networks: Control Panels for Cell Fate Specification.
- Published in:
- Genetics, 2019, v. 213, n. 4, p. 1093, doi. 10.1534/genetics.119.302661
- By:
- Publication type:
- Article
Evidence for Local Regulatory Control of Escape from Imprinted X Chromosome Inactivation.
- Published in:
- Genetics, 2014, v. 197, n. 2, p. 715, doi. 10.1534/genetics.114.162800
- By:
- Publication type:
- Article
Investigating the role of gap junctions in seizure wave propagation.
- Published in:
- Biological Cybernetics, 2019, v. 113, n. 5/6, p. 561, doi. 10.1007/s00422-019-00809-6
- By:
- Publication type:
- Article
CML-375: AIM4CML Trial in Progress: A Phase IIIb Study of Asciminib Monotherapy in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) with and without T315I Mutations.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S334, doi. 10.1016/S2152-2650(21)01782-1
- By:
- Publication type:
- Article
CML-413: Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S335, doi. 10.1016/S2152-2650(21)01784-5
- By:
- Publication type:
- Article
CML-417: ASCEMBL Phase 3 Health-Related Quality of Life (HRQL) Comparison of Asciminib and Bosutinib for Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or More Tyrosine Kinase Inhibitors (TKI).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S336, doi. 10.1016/S2152-2650(21)01785-7
- By:
- Publication type:
- Article
CML-353: Health Care Resource Utilization (HCRU) with Asciminib and Bosutinib among Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 Tyrosine Kinase Inhibitors (TKIs): Results from the Multicenter, Open-Label Phase 3 ASCEMBL Trial
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S334, doi. 10.1016/S2152-2650(21)01781-X
- By:
- Publication type:
- Article
CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S328, doi. 10.1016/S2152-2650(21)01769-9
- By:
- Publication type:
- Article
Poster: CML-417: ASCEMBL Phase 3 Health-Related Quality of Life (HRQL) Comparison of Asciminib and Bosutinib for Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or More Tyrosine Kinase Inhibitors (TKI).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S224, doi. 10.1016/S2152-2650(21)01412-9
- By:
- Publication type:
- Article
Poster: CML-353: Health Care Resource Utilization (HCRU) with Asciminib and Bosutinib among Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 Tyrosine Kinase Inhibitors (TKIs): Results from the Multicenter, Open-Label Phase 3 ASCEMBL Trial
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S224, doi. 10.1016/S2152-2650(21)01411-7
- By:
- Publication type:
- Article
Poster: CML-375: AIM4CML Trial in Progress: A Phase IIIb Study of Asciminib Monotherapy in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) with and without T315I Mutations.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S224, doi. 10.1016/S2152-2650(21)01410-5
- By:
- Publication type:
- Article
Poster: CML-413: Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S224, doi. 10.1016/S2152-2650(21)01409-9
- By:
- Publication type:
- Article
Poster: CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S223, doi. 10.1016/S2152-2650(21)01408-7
- By:
- Publication type:
- Article
Oral Abstract: CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S202, doi. 10.1016/S2152-2650(21)01274-X
- By:
- Publication type:
- Article
DASFREE: Treatment-Free Remission (TFR) After Discontinuation of Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Deep Molecular Response (DMR).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S299, doi. 10.1016/j.clml.2019.07.253
- By:
- Publication type:
- Article
Combination of Asciminib+Nilotinib or Asciminib+Dasatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S290, doi. 10.1016/j.clml.2019.07.236
- By:
- Publication type:
- Article
Efficacy and Safety of Asciminib, a Specific Allosteric BCR-ABL1 Inhibitor Targeting the Myristoyl-Binding Site, in Patients with Chronic Myeloid Leukemia (CML) Carrying the T315I Mutation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S289, doi. 10.1016/j.clml.2019.07.234
- By:
- Publication type:
- Article